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Purpose. Myopia is a global public health issue; however, no information exists as to how 
potential myopia retardation strategies are being adopted globally. 
Methods. A self-administrated, internet-based questionnaire was distributed in six 
languages, through professional bodies to eye care practitioners globally. The questions 
examined: awareness of increasing myopia prevalence, perceived efficacy and adoption of 
available strategies, and reasons for not adopting specific strategies. 
Results. Of the 971 respondents, concern was higher (median 9/10) in Asia than in any 
other continent (7/10, p < 0.001) and they considered themselves more active in 
implementing myopia control strategies (8/10) than Australasia and Europe (7/10), with 
North (4/10) and South America (5/10) being least proactive (p < 0.001). Orthokeratology 
was perceived to be the most effective method of myopia control, followed by increased time 
outdoors and pharmaceutical approaches, with under-correction and single vision spectacles 
felt to be the least effective (p < 0.05). Although significant intra-regional differences existed, 
overall most practitioners 67.5 (±37.8)% prescribed single vision spectacles or contact 
lenses as the primary mode of correction for myopic patients. The main justifications for their 
reluctance to prescribe alternatives to single vision refractive corrections were increased 
cost (35.6%), inadequate information (33.3%) and the unpredictability of outcomes (28.2%). 
Conclusions. Regardless of practitioners’ awareness of the efficacy of myopia control 
techniques, the vast majority still prescribe single vision interventions to young myopes. In 
view of the increasing prevalence of myopia and existing evidence for interventions to slow 
myopia progression, clear guidelines for myopia management need to be established. 
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The prevalence of myopia has approximately doubled in the past three decades, [1-3] 
arguably reaching epidemic levels. Prevalence rates of 70 to 87 % have been reported 
amongst populations of schoolchildren and young adults in Asia, [1, 4-8] and around 20-50% 
in America and Europe. [9-12] Moreover, the onset of myopia in the last two generations has 
been reported to occur earlier [1, 13, 14] leading to an increased prevalence of high myopia 
(≥ -6.00 D). High myopia is strongly associated with an increased risk of sight-threatening 
pathological ocular comorbidities, [1, 15] including retinal detachment, glaucoma, and 
cataract. [16-21] A study conducted in Taiwan, [1] comparing the age of onset and 
prevalence of myopia amongst schoolchildren from 1983 to 2000, shows an alarming shift 
towards a more myopic refractive error in recent years; in 1983, the mean onset of myopia 
was 11 years, whereas, in 2000, it was eight years; the mean refractive status observed at 
eight years of age was 0.45 ± 1.03 D and -0.15 ± 1.40 D in 1983 and 2000, respectively, 
whereas at 11 years of age it was -0.27 ± 1.72 D and -1.20 ± 1.93 D, respectively.  
 
A range of factors including genetic predisposition, [22-27] inadequate near accommodation 
response, [28, 29] elevated AC/A ratio/esophoria, [30, 31] excessive time spent undertaking 
near work, [25, 32-34] low levels of outdoor activity, [35-39] lighting levels [36, 40, 41] and 
the magnitude of hyperopic peripheral defocus [42-50] have been linked to the development 
and/or progression of myopic refractive error. However, the exact mechanisms surrounding 
both myopia development and progression are not yet fully understood as the disease 
appears to be multifactorial in nature. 
 
Over the past few years, there has been significant research and clinical interest in so-called 
‘myopia control’ approaches, being clinical methods which are designed to be beneficial for 
attenuating childhood myopic progression. Sankaridurg and Holden [51] discussed the 
potential benefit that a six year-old east-Asian child with -1.00 D of myopia could have, at 
age 15 years, if myopia progression was reduced by 30.0%, using an evidence-based model 
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of progression rates of myopia. If this child’s myopia progressed at the rate predicted by 
available natural history data, they would be expected to develop myopia in the order of -
7.00 D by 15 years of age. If the myopia progression had been retarded by an estimated 
30% over the eight-year follow-up period, then -5.50 D of myopia would be predicted. In a 
review paper, Flitcroft [17] highlighted that the higher the myopic refraction, the higher the 
odds ratio for myopic maculopathy, retinal detachment and, to a lesser extent, glaucoma and 
cataract. For example, compared to an emmetropes, the odds ratio for developing myopic 
maculopathy is 40.6 (95% confidence interval: 13.3-124.4) for myopia of -5.00 to 6.99 D, but 
increases to 126.8 (34.0-472.3) for myopia of -7.00 to 8.99 D. [17, 21] Similarly, the odds 
ratio for developing retinal detachment is 21.5 (17.3-26.7) for myopia of -5.00 to 6.99 D, but 
increases to 44.2 (34.2-57.2) for myopia of -7.00 to 8.99D. [17, 52] It has been estimated 
that reducing the rate of myopia progression by 33% would lead to a reduction of 73% in the 
frequency of high myopia (<-5.00D). [53] Lower levels of myopia have a reduced risk, but as 
the number of people with lower levels of myopia is greater, the public health risk of any 
myopia is still significant. [17] 
 
Multiple options are currently available for myopic refractive correction, including single 
vision, bifocal and progressive addition lens (PALs) spectacles, soft and rigid contact lenses 
(including orthokeratology) and refractive surgery. However, the relative contribution of these 
clinical methods for retarding myopia progression has only been more thoroughly 




Figure 1: Comparative studies [53-76] of the effectiveness (over the evaluated period) 
of different techniques to retard the progression of myopia. 
 
It has been suggested that conventional single vision spectacle lenses may be ineffective for 
myopia control as they induce peripheral hyperopic defocus, a factor speculated to promote 
eye growth. [47, 48, 77, 78] However some authors have questioned whether peripheral eye 
focus is the primary mechanism driving eye growth, as they reported that some myopic 
children wearing single vision spectacles had greater relative myopic defocus, and thus 
myopia progression was less than it was in those children wearing single vision spectacles 
with relatively greater hyperopic defocus. [67, 79] Other large studies in humans have also 
found peripheral refraction to neither affect myopia onset or development. [64, 80] 
Progressive addition and bifocal lenses have been prescribed to reduce accommodative 
demand, and mitigate the blur associated with increased lag of accommodation in myopia. 
[28, 29, 31, 64] It is presumed that an insufficient amount of accommodation might cause a 
relative retinal blur and, hence, be a triggering factor for axial elongation. The success rate 
of studies employing PALs and bifocals have varied from no effect [65, 81] to 46% for PALs 
6 
 
(although this study was not randomised), [66] and 44 to 56 % for bifocals and executive 
bifocals. [59, 61] However, other studies have reported retardation rates of 14% to 24% [60, 
64, 66, 82, 83] which are less convincing. 
 
Under-correction, which was believed not only to reduce accommodative demand, but 
induce myopic defocus, has been hypothesised to act as a halting signal to myopia 
development in animal studies. [84, 85] Contrarily, under-correction has been found to 
accelerate the rate of myopia progression by 17 to 29% in human clinical studies. [57, 58] 
 
Soft single vision contact lenses [86-88] and conventional rigid gas permeable (RGP) 
contact lenses [87, 89, 90] have been found to have no effect on myopia progression. 
However, multifocal contact lens designs appear to be effective in reducing myopia 
progression (by 34 to 50%) and may be more effective than bifocal or PAL spectacle lens 
designs; this may result from the optics of a contact lens, including the near portion, being 
consistently aligned with the position of gaze because the lens moves with the eye, [64, 71, 
91] and possibly more consistency in wearing time which seems to be an important factor for 
efficacy. [92] Orthokeratology studies are remarkably consistent in the level of myopia 
retardation shown, being around 50%. [74-76] and is considered at present the optical 
treatment with the strongest accumulated evidence. [93] 
 
Pharmaceutical treatment strategies, such as atropine [56, 81, 94] and pirenzepine, [55, 95, 
96] have shown high success rates (32% to 72%). However, there has been a lack of 
consensus for the optimum concentration to prevent unwanted side-effects during treatment, 
and the rebound effect following cessation of treatment. [55, 59, 83, 97, 98]  
 
Epidemiology studies in the general population, and in monozygotic twins, have generally 
demonstrated that time spent outdoors reduces the likelihood of myopia onset. [99-102] The 
behavioural approach of increased outdoor activity has been shown to retard the onset of 
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myopia by 11-34%. [54] It is postulated that the higher luminance levels, which exist 
outdoors compared to indoors, trigger the release of the retinal transmitter, dopamine, which 
is believed to prevent axial growth and myopia development. [36, 40, 41] In addition, it has 
been suggested that components of sunlight itself, could activate particularly vitamin D, 
which could play a potential role in preventing eye growth. [36, 103] Furthermore, viewing 
distances are generally greater outdoors compared to indoors, removing accommodative 
demand and retinal image quality could improve as pupil diameter is smaller in bright light, 
increasing depth of focus. [38] 
 
However, if and how these approaches are employed in clinical practice is still unclear. In 
2013 the Vision Research Institute (Ferris State University Michigan Collage of Optometry) 
conducted a survey concerning the increasing rates of myopia prevalence (available online: 
http://www.myopiacontrol.org/how-do-you-myopia-control-.html). Results showed that 
practitioners in United States of America were aware of the growing issue and tended to 
familiarise themselves with the current literature in the field. However, their rationale for 
prescribing, or the frequency of choosing different management strategies was not included 
in the survey. Likewise, Contact Lens Spectrum has also surveyed over 400 practitioners in 
the United States of America in both 2014 and 2015 showing that in both years, 24% of 
practitioners report using contact lenses to control myopia; practitioners reported using soft 
multifocals and orthokeratology contact lens designs predominantly, with very few reporting 
rigid multifocals. [104]  Several studies have reported statistically, but not clinically, 
significant reductions in the rates of myopia progression retardation (see Figure 1) and some 
authors doubt the retardation effect achieved, [60] presumably leaving practitioners confused 
and sceptical about the various management strategies available. Therefore, a better 
understanding of current trends of myopia management in clinical practice is required before 




A self-administrated, internet-based cross-sectional survey in English, French, Spanish, 
Italian, Portuguese and Chinese was distributed using software SurveyMonkey (Palo Alto, 
California, USA) through various professional bodies across the world to reach eye care 
professionals (optometrists, dispensing opticians, ophthalmologists and others) globally. The 
survey comprised of nine questions relating to the self-reported clinical management 
behaviours of practitioners for progressive myopia and practitioner’s current opinions on 
myopia related clinical care including: 
 level of concern about the increasing frequency of paediatric myopia in their 
clinical practice (rated as ‘Not at all,’ to ‘extremely,’ on a 10 point scale) 
 perceived effectiveness, defined as the expected level of reduction in 
childhood myopia progression of a range of myopia control options (rated as 
a percentage from 0 to 100%) 
 how active they would consider their clinical practice in the area of myopia 
control (rated as ‘Not at all,’ to ‘fully,’ on a 10 point scale) 
 frequency of prescribing different myopia correction options for progressive / 
young myopes during a typical month  
 minimum age a patient would need to be for them to consider myopia 
refractive correction options (assuming average handling skills and 
child/parent motivation) 
 minimum amount of myopia that would need to be present to consider myopia 
refractive correction options (specified in half dioptre steps) 
 minimum level of myopia progression that would prompt a practitioner to 
specifically adopt a myopia control approach (specified in quarter dioptre 
steps) 
 frequency of adopting single vision under-correction as a strategy to slow 
myopia progression (reported as ‘no,’ ‘sometimes,’ or ‘always’)? 
 if they had only ever fitted single vision spectacles/contact lenses for myopic 
patients, what had prevented them (multiple options could be selected) from 
prescribing alternative refractive correction methods; options consisted of: 
o They don’t believe that these are any more effective 
o The outcome is not predictable 
o Safety concerns 
o Cost to the patient makes them uneconomical 
o Additional chair time required 
o Inadequate information / knowledge 
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o Benefit / risk ratio 
o Other 
 
There was an option to add further comments to each of the questions and the topic as a 
whole. Voluntary participation in the survey, following an explanation of the research, was 
anonymous, however, respondents were asked to provide basic demographic information 
about themselves (highest qualification, years of being qualified and everyday working 
environment). The data was collected between January and June 2015. 
 
Statistical Analysis 
Statistical analysis was conducted with SPSS (v21 IBM, New York, USA). Only complete 
surveys were analysed. Median, mean and standard deviations were calculated for each 
question response, with the results grouped by continent (Asia, Australasia, Europe, North 
America and South America) and countries within a continent where response rate allowed 
(n ≥ 30), with Kruskal-Wallis tests applied to determine statistical difference (taken as p < 
0.05) between them. For conciseness, only significant comparisons have been reported. 






The total number of 971 complete survey responses were received, with the distribution by 
continent being: Africa 7 (not included in further analysis), Asia 291, Australasia 119; Europe 
339; North America 133; and South America 82. Country specific responses could be 
extracted from: 
 Europe: France (n = 34), Italy (n = 72), Netherlands (n = 38) Portugal (n = 48), Spain 
(n = 34) and UK/EIRE (n = 52) 
 Asia: China (n = 137), Hong Kong (n = 61) and India (n = 37) 
 North America; Canada (n = 33) and USA (n = 100) 
Of the study participants, 72.4% (n=698) were optometrists, 18.6% (n = 180) were 
ophthalmologists, 5.8% (n = 56) were contact lens opticians and 3.2% (n = 31) were other 
types of eye care specialists. The principal working environment for 84.4% was in clinical 
practice (n = 814), 11.3% worked in academia (n = 109), 1.6% worked within industry (n = 
16) and 2.7% (n = 26) worked in other environments. However, all study participants were 
registered eye care practitioners. The median number of years qualified was the 11-20 
category, with a normal distribution.   
 
Self-reported concern about the increasing frequency of paediatric myopia (Figure 2) 
Practitioners’ concern about increasing frequencies of paediatric myopia in their practices 
was higher (median 9/10) in Asia than any of the other continents (p < 0.001), with a similar 
level of concern (all with a median of 7/10; p > 0.05) across Australasia, Europe, North and 
South America. In Asia, Chinese practitioners were more concerned (8.8 ± 1.5) than those in 
Hong Kong (7.9 ± 1.7; p = 0.001) or India (7.3 ± 2.6; p = 0.002). In Europe, Portuguese (8.2 
± 3.2) and Spanish (8.3 ± 2.3) practitioners were more concerned than those in Italy (6.9 ± 
2.5; p = 0.046, p = 0.027 respectively), the Netherlands (6.3 ± 2.1; p = 0.002, p = 0.001) or 
the UK/EIRE (5.8 ± 2.6; p < 0.001, p < 0.001). In North America, practitioners from the USA 




Figure 2: Level of practitioner concern (rated from 0-10) regarding the perceived 
increasing frequency of paediatric myopia in their practice for practitioners 
located in different continents. N=965. Error bars = 1 SD 
 
Perceived effectiveness of myopia control options (Table 1) 
Overall, orthokeratology was perceived by practitioners to be the most effective method of 
myopia control, followed by increased time outdoors and pharmaceutical approaches. Single 
vision distance under-correction and single vision spectacles were perceived to be the least 
effective method. These findings were consistent across all continents except for South 
America (p < 0.05), where all the modalities were perceived to be similarly effective (12-
24%), except for time spent outdoors (35%). Compared with practitioners from all other 
continents, Asians practitioners considered single vision, bifocal and progression addition 
lenses to be relatively more effective for reducing childhood myopia progression (p < 0.01). 
Australian and North American practitioners perceived single vision contact lenses as less 
effective than practitioners from other continents (p < 0.01). North American practitioners 
had less confidence in orthokeratology and pharmaceuticals as appropriate methods for 
myopia control than those from Asia or Australasia (p = 0.001); the same was true of 
European practitioners with respect to pharmaceuticals (p < 0.001). North Americans were 
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also more sceptical about the potential benefit of increasing time spent outdoors on myopia 
progression compared with practitioners from other continents (p < 0.05). Intra-region 
comparisons showed that there were wide variations in perceived effectiveness across all 
myopia control options. 
 Continent 










 Under-correction 6.5 ± 13.9 2.5 ± 7.4 6.4 ± 15.8 2.9 ± 7.9 13.4 ±  23.1 
Single Vision   16.0 ± 23.6 4.2 ± 12.5 10.0 ± 21.8 4.0 ± 14.0 18.1 ± 30.7 
Bifocals 18.4 ± 21.1 14.1 ± 14.8 12.4 ± 17.5 11.6 ± 14.4 12.3 ± 24.2 
Progressive 








s Rigid Gas 
Permeable (RGP) 23.9 ± 26.9 9.6 ± 13.8 14.1  ± 20.8 9.9 ± 15.4 13.6 ± 27.0 
Single Vision Soft 11.9 ± 20.6 4.1 ± 11.5 10.1 ± 20.5 2.9 ± 10.5 16.0 ± 29.0 
Multifocal Soft 15.5 ± 20.2 22.5 ± 19.3 16.4 ± 25.7 18.4 ± 20.5 11.5 ± 19.7 
Novel Myopia 
Control Soft 24.4 ± 26.0 29.1 ± 19.3 25.2 ± 25.7 21.5 ± 23.1 18.8 ± 28.5 
Orthokeratology 48.6 ± 29.6 47.8 ± 25.3 44.3 ± 29.0 36.9 ± 30.1 23.9 ± 32.3 
  Pharmaceutical 31.7 ± 27.8 39.0 ± 32.4 24.2 ± 29.4 21.8 ± 27.0 14.6 ± 23.3 
  Refractive Surgery 17.4 ± 29.7 11.4 ± 24.3 12.8 ± 25.6 13.5 ± 30.6 18.0 ± 29.4 
  Increased Time 
Outdoors  38.7 ± 27.5 29.7 ± 22.0 29.4 ± 26.2 20.5 ± 17.9 35.3 ± 32.0 
Table 1: Perceived effectiveness (defined as the expected level of reduction in 
childhood myopia progression in percent) of myopia control options by 
practitioners in different continents. Data are expressed as mean ± S.D. 
 
Perceived level of clinical activity in the area of myopia control (Figure 3) 
Asian practitioners considered their clinical practice of myopia control to be more active 
(median 8/10) than practitioners from Australasian (median 7/10; p = 0.028), European 
(median 7/10; p < 0.001), North American (median 4/10; p < 0.001) or South American 
practitioners (median 5/10, p < 0.001). North American practitioners perceived themselves to 
be relatively less active in this area of practice than those from Europe (p < 0.001) and 
Australasia (p < 0.001). Within Europe there were no differences between countries, 
however, within Asia, Indian practitioners (6.05 ± 1.99) considered themselves relatively less 
active than Chinese (7.96 ± 1.96; p < 0.001) or Hong Kong (7.31 ± 2.20; p = 0.002) 
practitioners. Within North America, and Canadian practitioners (3.97 ± 3.42) considered 




Figure 3: Perceived level of clinical activity in the area of myopia control for practitioners 
located in different continents. N=964. Error bars = 1 SD 
 
Frequency of prescribing different myopia correction options for progressing / young myopes 
(Table 2) 
The majority of progressing myopes were being prescribed either single vision (full 
correction) spectacles (47.8 ± 31.7%) or single vision contact lenses (15.2 ± 17.3%).  
Orthokeratology (14.3 ± 24.3%), PAL spectacles (6.5 ± 14.3%), RGPs (4.5 ± 10.5%), 
multifocal contact lenses (4.1 ± 11.3%), bifocal spectacles (2.6 ± 8.2%), novel myopia 
control contact lenses (2.1 ± 7.9%), pharmaceuticals (1.9 ± 8.7%) and refractive surgery (1.0 
± 5.4%) were utilised relatively less frequency. Asian practitioners indicated prescribing 
single vision (full correction) spectacles most frequently, whereas those from Australia 
prescribed them least often (p < 0.001). North American practitioners indicated prescribing 
bifocal spectacles most frequently (p < 0.001) for progressing / young myopes. Australian 
practitioners, and to a lesser degree, Asian practitioners, prescribed PALs more frequently (p 
< 0.001) than those from other continents. Australians and North American practitioners 
prescribed RGPs (p < 0.001) less frequently to these patients. Asian practitioners prescribe 
single vision contact lenses (p < 0.001) least often, while North American practitioners 
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prescribed more standard multifocal contact lenses (p < 0.001) than other regions. Few 
novel myopia control soft contact lenses are being prescribed in any continent. South 
American practitioners prescribed orthokeratology least frequently (p < 0.001). Asian 
practitioners indicated utilising pharmaceuticals more frequently (p < 0.001) than 
practitioners from other continents for progressing / young myopes. Asian and South 
American practitioners recommended refractive surgery more than other continents for these 
patients, but the prescribing frequency was still low (p < 0.001). Intra-region comparison 
showed large variations in prescribing habits for all myopia control options. 
 
Continent  











Single Vision   57.6 ± 31.3 36.8 ± 30.2 42.2 ± 30.7 49.6 ± 31.3 52.1 ± 30.5 
Bifocals 2.9 ± 7.3 1.3 ± 4.4 2.1 ± 7.0 5.1 ± 13.6 1.9 ± 7.0 
Progressive 
Addition (PALs) 











4.9 ± 8.5 0.6 ± 2.1 6.1 ± 13.6 2.4 ± 8.3 6.8 ± 10.8 
Single Vision Soft 5.7 ± 9.9 13.9 ± 13.4 20.2 ± 18.8 18.8 ± 16.5 21.0 ± 20.3 
Multifocal Soft 0.8 ± 2.9 6.2 ± 11.9 4.3 ± 11.0 8.5 ± 17.5 2.1 ± 7.2 
Novel Myopia 
Control Soft 
2.2 ± 8.1 1.5 ± 4.7 2.4 ± 8.8 0.9 ± 5.1 3.0 ± 10.6 
Orthokeratology 11.1 ± 17.6 21.2 ± 29.1 18.3 ± 27.6 9.4 ± 18.5 7.9 ± 25.2 
  Pharmaceutical 5.6 ± 14.5 0.8 ± 3.3 0.1 ± 1.2 1.1 ± 6.8 0.7 ± 5.0 
  Refractive Surgery 2.0 ± 8.3 0.3 ± 1.3 0.3 ± 1.6 0.6 ± 4.5 2.8 ± 7.6 
Table 2: Frequency of prescribing myopia correction options for progressing / young 
myopes by practitioners in different continents for progressing / young 
myopes. Data are expressed as mean ± S.D. 
 
Minimum patient age that practitioners consider myopia correction options (Table 3) 
Single vision spectacles were prescribed from the youngest age (5.4 ± 1.5 years). Multifocal 
spectacles (bifocal: 6.3 ± 2.3 years; PAL: 7.3 ± 2.8 years) and pharmaceuticals (6.4 ± 2.6 
years) tended to be reserved for older children. Contact lenses were only considered 
appropriate for older children, especially those intended specifically for myopia control 
(single vision: 6.5 ± 3.4 years; novel myopia control soft: 8.8 ± 3.1 years; orthokeratology: 
8.8 ± 3.1 years; multifocal: 8.9 ± 3.1 years; RGPs 9.9 ± 3.3 years). Most practitioners did not 
recommend refractive surgery to patients under 18 years of age. For single vision 
spectacles, bifocal spectacles and PALs, European and Asian practitioners were more 
conservative in their minimum fitting age (p < 0.05) than Australasian or North American 
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practitioners. Asian and South American practitioners were more conservative in their 
minimum fitting age of all soft contact lens modalities than Australian, European or North 
American practitioners (p < 0.01). There was no difference between regions in the minimum 
age they would consider prescribing RGP contact lenses, pharmaceuticals or refractive 
surgery correction options (p > 0.05).  
 
Within Europe, practitioners from the Netherlands were the most conservative in their 
minimum age for fitting single vision spectacles (p < 0.001). French practitioners were most 
conservative in their minimum age for fitting single vision contact lenses compared to those 
from the rest of the continent, with the exception of Portuguese practitioners, who were 
conservative with their minimum fitting age of all types of contact lenses (p < 0.05). Indian 
practitioners were more conservative than Chinese practitioners on the minimum fitting age 
for RGPs (p = 0.003), whereas Chinese practitioners were more conservative in their 
minimum fitting age for single vision soft contact lenses than those from either Hong Kong or 
India (p < 0.05). Orthokeratology was considered at an earlier age in Hong Kong than India 
or China (p<0.001) and in the USA than in Canada (p = 0.029). Pharmaceuticals were 
considered at an earlier age in China than in Hong Kong or India (p = 0.001). 
 
Continent  











Single Vision   5.9 ± 3.9 (1) 5.3 ± 0.5 (6) 7.4± 3.0 (6) 5.2 ± 0.6 (4) 5.5 ± 1.2 (11)
Bifocals 6.6 ± 2.6 (37) 6.0 ± 1.3 (32) 7.4 ± 2.6 (48) 5.1 ± 0.5 (21) 7.5 ± 2.9 (66)
Progressive 
Addition (PALs) 











10.1 ± 3.3 
(20) 
9.0 ± 1.7 (32) 7.9 ± 2.4 (22) 9.3 ± 3.0 (24) 10.2 ± 4.3 
(24) 
Single Vision Soft 
10.9 ± 3.8 
(24) 
8.3 ± 0.8 (8) 7.8 ±2.7 (8) 7.9 ± 2.4 (7) 10.3 ± 3.7 
(11) 
Multifocal Soft 
11.1 ± 4.0 
(52) 




10.8 ± 3.5 
(30) 
8.3 ± 0.8 (25) 7.3 ± 2.5 (32) 7.9 ±2.6 (33) 10.3 ± 3.9 
(45) 
Orthokeratology 
9.6 ± 3.2 (8) 8.0 ± 1.1 (13) 8.1 ± 2.3 (17) 8.0 ± 3.1 (30) 12.3 ± 4.8 
(49) 
  Pharmaceutical 6.4 ± 2.6 (44) 6.7 ± 3.9 (65) 7.9 ± 3.6 (87) 6.4 ± 3.3 (62) 6.3 ± 2.2 (64)
  Refractive Surgery 
16.9 ± 2.9 
(50) 
18.0 ± 0.0 
(83) 
12.8 ± 4.5 
(83) 
18.0 ± 0.0 
(71) 




Table 3: Minimum patient age considered necessary by practitioners (from different 
continents who prescribed these options for different myopia correction 
options. Data are expressed as mean ± S.D years (% that would not prescribe 
this refractive modality). 
 
Minimum degree of myopia that needs to be present for practitioners to consider myopia 
control options (Table 4) 
Overall practitioners indicated that myopia would be corrected with single vision spectacles 
at a lower degree (-1.07 ± 0.90 D) than it would with refractive surgery (-3.06 ± 1.62 D). All 
other modalities would be considered at approximately -2.00 D. Asian practitioners required 
a higher level of myopic refractive error before they would consider single vision spectacles 
than all other regions (p < 0.01). Australasian practitioners were willing to fit bifocals and 
PALs at a lower level of myopia than Asian, European or South American clinicians (p < 
0.01). North American practitioners prescribed bifocal and PALs to children with a lower 
degree of myopia than those from Asia (p = 0.001). However, Asian practitioners would 
consider single vision soft contact lenses, novel myopia control contact lenses, 
orthokeratology and pharmaceutical intervention at a lower level of myopia than those from 
Australasia or Europe (p < 0.01), and single vision soft contact lenses and pharmaceutical 
treatment than those from North and South America (p < 0.01). Multifocal contact lenses 
were considered at a lower level of myopia by Australasian practitioners than those from 
Asia, Europe or South America (p < 0.01). Asian practitioners required a higher level of 
refractive error before they would consider fitting RGPs than those from Europe and North 
America (p < 0.01). Asian and European practitioners would consider recommending 
refractive surgery at a significantly higher level of myopia than those from Australasia, North 
or South America (p < 0.05). Within Europe, Portuguese and French practitioners required a 
higher level of refractive error before they would consider fitting RGPs than those from other 
European nations (p < 0.05). Portuguese practitioners also required a higher level of 
refractive error before they would consider orthokeratology (p<0.01) or refractive surgery (p 
< 0.001) than practitioners from other European nations. Indian practitioners required a 
higher level of refractive error before they would consider bifocals (p < 0.05), PALs (p < 0.01) 
or orthokeratology (p = 0.001) than practitioners from China or Hong Kong. Chinese 
practitioners considered prescribing pharmaceuticals to children with a lower level of myopia 
(-0.66 ± 0.4D) compared to practitioners from India (-2.86 ± 1.01D) or Hong Kong (-2.39 ± 
1.75D; p < 0.001). The only difference across North America was that Canadian practitioners 
required a higher level of refractive error before they would consider PALs (p = 0.012) than 

















Single Vision   -1.2 ± 1.0 -0.8 ± 0.3 -0.8 ± 0.9 -0.8 ± 0.7 -1.3 ± 0.4 
Bifocals -1.8 ± 1.1 -0.8 ± 0.4 -1.8 ± 1.4 -1.1 ± 0.7 1.5 ± 0.0 
Progressive 
Addition (PALs) 











-3.1 ± 1.9 -2.8 ± 1.4 -2.2 ± 1.8 -1.5 ± 1.4 -1.8 ± 0.4 
Single Vision Soft -2.6 ± 1.8 -1.8 ± 0.9 -1.1 ± 0.8 -0.9 ± 0.7 -1.5 ± 0.0 
Multifocal Soft -2.6 ± 1.7 -1.8 ± 1.0 -1.9 ± 1.5 -1.1 ± 0.7 -1.5  ± 0.0 
Novel Myopia 
Control Soft 
-2.7 ± 1.8 -1.7 ± 0.9 -1.9 ± 1.5 -1.5 ± 1.2 -1.5  ± 0.0 
Orthokeratology -2.4 ± 1.5 -1.6 ± 0.8 -2.3 ± 1.6 -1.5 ± 1.2 -1.5  ± 0.0 
  Pharmaceutical -1.6 ± 1.5 -2.1 ± 0.9 -3.1 ± 1.6 -1.5 ± 1.3 -2.5  ± 2.1 
  Refractive Surgery -3.5 ± 1.6 -2.9 ± 1.5 -2.9 ± 1.5 -1.7 ± 1.3 -2.8  ± 1.8 
Table 4: Minimum level of patient myopia (in dioptres) before myopia correction 
options would be considered by practitioners from different continents who 
prescribed these options. Data are expressed as mean ± S.D. 
 
Minimum annual amount of patient myopia progression that would prompt a practitioner to 
specifically adopted a myopia control approach (Figure 4) 
The minimum myopia progression rate that practitioners considered warranted a myopia 
control approach was 0.51 to 0.75 D/year for the majority of respondents (31.1%), with 74% 
indicating a level between 0.25 and 1.00 D/year. Australian practitioners indicated that they 
would adopt myopia control strategies for myopia progressing at slower rates than 
practitioners from Asia, North or South American (p < 0.001). European practitioners would 
be willing to treat myopia progression at slower rates than those from Asian (p < 0.001) or 
South American (p = 0.003). There were no differences in the minimum annual myopia 
progression between Europe (p = 0.090), Asia (p = 0.365) or North America (p = 0.057). 
Other factors influencing practitioners’ management decisions, as identified from the free 
text responses, included family history of myopia (6 respondents), age of myopia onset (10 
respondents), absolute degree of refractive error at the time (2 respondents), ocular 
biometry (3 respondents), environmental factors/lifestyle (6 respondents), lighting exposure 




Figure 4: Minimum annual amount of patient myopia progression, in dioptres per year 
(D/year), that practitioners located in different continents considered to 
necessitate a myopia control approach. N=964.  
 
Use of single-vision under-correction as a strategy to slow myopia progression (Figure 5) 
Overall, most practitioners did not consider single-vision distance under-correction to be an 
effective strategy for attenuating myopia progression (72.7%). South American practitioners 
used this strategy relatively more than those from Australia, Asia or North America (p < 
0.01). Within Europe, Spanish and Portuguese practitioners indicated using under-correction 
as a strategy to control myopia more than those from the UK and EIRE (p < 0.05). Within 
Asia, Indian practitioners utilised under-correction more than those from China or Hong Kong 
(p < 0.001). Within North America, there was no difference in the use of under-correction 




Figure 5: Use of single-vision distance under-correction as a strategy to slow myopia 
progression by practitioners located in different continents. N=964.  
 
Factors preventing the prescription of a myopia control approach (Figure 6) 
The most common reasons practitioners gave for not adopting myopia control strategies 
were: they were felt to be uneconomical (35.6%); they considered there to be inadequate 
information about the modalities (33.3%); they viewed the outcomes to be unpredictable 
(28.2%); concerns about safety (25.3%); they perceived them to be ineffective for reducing 
myopia progression (23.8%); and the benefit to risk ratio was too low (20.5%). There was no 
significant difference in the distribution of these factors between or within continents (p > 
0.05). Free text comments identified other factors affecting the prescription of these 
strategies to relate to the relative availability of the myopia control treatments and the 






Figure 6: Factors preventing practitioners located in different continents from 






This is the first study to examine the self-reported attitudes and practices of eye care 
practitioners towards myopia control approaches across the globe. Close to one thousand 
practitioners responded, principally spread over five continents. The exact response rate is 
not known, as maximum coverage was promoted by involving professional bodies whose 
members may not all be practicing eye care practitioners. However, it may be presumed that 
questionnaires are completed both by people cynical and enthusiastic to the issue being 
examined, balancing the average response. In addition, the recruitment approach across 
nations was the same, allowing cross-national comparisons. The majority of the respondents 
(91.0%) were optometrists and ophthalmologists, reflecting those professions legally allowed 
to prescribe vision care correction and, in many regions, pharmaceuticals as well. 
    
As one might expect from the high prevalence rates of myopia in Asia, Asian practitioners, 
especially those practicing in China, were more concerned about the increasing prevalence 
of paediatric myopia in their practices than clinicians in any of the other continents. A similar 
pattern existed in relation to how active they considered their clinical practice in the area of 
myopia control. Myopia prevalence was approximately 30% in 30-35 year olds in Spain [105]  
and may be increasing in Portugal, [106] but is as high as 58% in Italian university students 
and 28% in Dutch school children; [107] hence it is unclear why the former country’s 
practitioners are more concerned than the latter. The prevalence of myopia in the USA was 
around 30%, [11] but the myopia occurrence is not documented in Canada to warrant their 
lower concern. 
 
Orthokeratology was correctly perceived by eye care practitioners to be one of the most 
effective methods for attenuating childhood myopia progression. However, the effectiveness 
of pharmaceutical approaches were underestimated by practitioners and increased time 
spent outdoors overestimated compared to current evidence (Figure 1). Differences in 
lifestyle, such as population density might affect perceived effectiveness of approached such 
as perceived time spent outdoors. While single-vision distance under-correction has been 
shown fairly conclusively to increase, rather than decrease, the rate of myopia progression in 
children, [57, 58] there were still practitioners who consider the converse to be true; this was 
confirmed by a question later in the survey, with under-correction still practiced as a method 
of myopia control by practitioners from South America, Spain and Portugal within Europe 
and India within Asia.   
 
Despite the self-perceived activity of practitioners in the area of myopia control, over two 
thirds of progressing and/or young myopes were being prescribed single vision spectacles or 
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contact lenses (68%), with continental and national differences in the adoption of refractive 
correction options known to reduce myopia progression. Approximately one third of 
practitioners not adopting myopia control approaches felt them to be uneconomical and/or 
that there was inadequate information about them; about one quarter of respondents 
suggested that outcomes were unpredictable and/or that myopia control methods were 
ineffective, with some also being concerned about the relative safety of these strategies. 
Further comments raised the issue of availability of some myopia control options, 
presumably of novel myopia control lenses, as current approaches are all off-label, 
highlighting the need for regulatory oversight and guidance. Limited access to necessary 
instrumentation was also raised as a potential barrier, as more advanced contact lens 
fittings, such as orthokeratology, require the use of corneal topography. Attempts to 
specifically manipulate peripheral retinal focus may also require instrumentation to rapidly 
and robustly assess peripheral retinal shape and/or refraction with myopia control 
ophthalmic medical devices. However, this strategy might not ‘translate’ well from animal 
studies to human trials. [79, 80] 
 
Spherical equivalent refractive error (measured under cycloplegia) is currently the single 
best predictive measure of juvenile myopia development, with children aged six years with 
less than +0.75D of hyperopia being at increased risk of developing myopia. [108] Most 
practitioners were comfortable fitting refractive corrections with basic optical designs and 
even pharmaceuticals to myopic patients of this age, but tended to wait until a child was 
older for more complex designs such as PALs, novel myopia control soft contact lenses and 
RGPs (including orthokeratology). Interestingly, one potential advantage of orthokeratology 
is that the parents or carer can manage lens application, removal and lens care, along with 
the lenses not having to leave the home, which can make this modality a popular option for 
parents or carers with younger myopic children. This is exemplified by Hong Kong, an early 
adopter of orthokeratology, where its use is considered at an earlier age than other countries 
in the region.  
 
Research suggests that lower levels of hypermetropia at a young age is a strong risk factor 
for myopia development, so it would seem that practitioners are far too conservative in 
waiting until mild-moderate levels of myopia are present before control approaches are 
considered. [80, 108] Myopia progresses at much faster rates in children in comparison to 
teenagers, thus supporting the need for earlier intervention. [109] There may also “window of 
opportunity” for myopia treatment according to the age of onset, rate of progression and 
myopia magnitude. [110] More research is needed on the relative benefits of myopia control 
strategies in adolescents and even young adults. Practitioners located in Asia considered 
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most myopia control approaches at a lower level of myopia than other continents, which is 
presumably due to this continent having one of the highest prevalences of myopia 
worldwide. Interestingly, Chinese practitioners considered prescribing pharmaceutical 
modalities at a younger age, and at a much lower level of myopia, compared with 
practitioners from other countries in the region. This may be due to different countries having 
different regulations and practitioners with different background (for example training, 
education and scope of practice), which can affect local practice, apart from the prevalence 
of myopia and need for correction or retardation. The rate of patient refractive progression 
that triggered practitioners to prescribe a myopia control approach largely mirrored the 
prevalence rate of myopia in each region; the higher the prevalence of myopia, the higher 
the level of myopia developed in individuals and the higher the risk of ocular pathology. [20] 
Practitioners understandably also identified several other factors that, combined with the 
degree of myopic progression, influenced their decision to prescribe myopia control 
approaches; these included family history, age of onset, absolute amount of refractive error 
at that time, ocular biometry, environmental factors / lifestyle, lighting exposure and the 
degree of parental support. [111]  
 
In conclusion, this global survey of current trends in eye care practitioner myopia 
management attitudes and strategies in clinical practice has identified that, despite growing 
evidence of the negative impact of even low levels of myopia on health economics, and 
moderate levels of practitioner concern and perceived activity (particularly where the 
prevalence of myopia is highest) uptake of appropriate techniques is generally poor. 
Furthermore, myopia control techniques are not being applied early enough in a child’s 
ocular development to elicit their optimum effect. Adequate education of practitioners is 
lacking, along with access to appropriately regulated myopia control ‘labelled’ products with 
efficacy and safety data. A guide needs to be developed to inform practitioners of 
economically viable models of eye care, including the development of instrumentation to 
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